Cargando…

Inactivation of aerosolized SARS‐CoV‐2 by 254 nm UV‐C irradiation

Surface residing SARS‐CoV‐2 is efficiently inactivated by UV‐C irradiation. This raises the question whether UV‐C‐based technologies are also suitable to decontaminate SARS‐CoV‐2‐ containing aerosols and which doses are needed to achieve inactivation. Here, we designed a test bench to generate aeros...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruetalo, Natalia, Berger, Simon, Niessner, Jennifer, Schindler, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538331/
https://www.ncbi.nlm.nih.gov/pubmed/36168221
http://dx.doi.org/10.1111/ina.13115
_version_ 1784803338803478528
author Ruetalo, Natalia
Berger, Simon
Niessner, Jennifer
Schindler, Michael
author_facet Ruetalo, Natalia
Berger, Simon
Niessner, Jennifer
Schindler, Michael
author_sort Ruetalo, Natalia
collection PubMed
description Surface residing SARS‐CoV‐2 is efficiently inactivated by UV‐C irradiation. This raises the question whether UV‐C‐based technologies are also suitable to decontaminate SARS‐CoV‐2‐ containing aerosols and which doses are needed to achieve inactivation. Here, we designed a test bench to generate aerosolized SARS‐CoV‐2 and exposed the aerosols to a defined UV‐C dose. Our results demonstrate that the exposure of aerosolized SARS‐CoV‐2 with a low average dose in the order of 0.42–0.51 mJ/cm(2) UV‐C at 254 nm resulted in more than 99.9% reduction in viral titers. Altogether, UV‐C‐based decontamination of aerosols seems highly effective to achieve a significant reduction in SARS‐CoV‐2 infectivity.
format Online
Article
Text
id pubmed-9538331
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95383312022-10-11 Inactivation of aerosolized SARS‐CoV‐2 by 254 nm UV‐C irradiation Ruetalo, Natalia Berger, Simon Niessner, Jennifer Schindler, Michael Indoor Air Original Articles Surface residing SARS‐CoV‐2 is efficiently inactivated by UV‐C irradiation. This raises the question whether UV‐C‐based technologies are also suitable to decontaminate SARS‐CoV‐2‐ containing aerosols and which doses are needed to achieve inactivation. Here, we designed a test bench to generate aerosolized SARS‐CoV‐2 and exposed the aerosols to a defined UV‐C dose. Our results demonstrate that the exposure of aerosolized SARS‐CoV‐2 with a low average dose in the order of 0.42–0.51 mJ/cm(2) UV‐C at 254 nm resulted in more than 99.9% reduction in viral titers. Altogether, UV‐C‐based decontamination of aerosols seems highly effective to achieve a significant reduction in SARS‐CoV‐2 infectivity. John Wiley and Sons Inc. 2022-09-21 2022-09 /pmc/articles/PMC9538331/ /pubmed/36168221 http://dx.doi.org/10.1111/ina.13115 Text en © 2022 The Authors. Indoor Air published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Ruetalo, Natalia
Berger, Simon
Niessner, Jennifer
Schindler, Michael
Inactivation of aerosolized SARS‐CoV‐2 by 254 nm UV‐C irradiation
title Inactivation of aerosolized SARS‐CoV‐2 by 254 nm UV‐C irradiation
title_full Inactivation of aerosolized SARS‐CoV‐2 by 254 nm UV‐C irradiation
title_fullStr Inactivation of aerosolized SARS‐CoV‐2 by 254 nm UV‐C irradiation
title_full_unstemmed Inactivation of aerosolized SARS‐CoV‐2 by 254 nm UV‐C irradiation
title_short Inactivation of aerosolized SARS‐CoV‐2 by 254 nm UV‐C irradiation
title_sort inactivation of aerosolized sars‐cov‐2 by 254 nm uv‐c irradiation
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538331/
https://www.ncbi.nlm.nih.gov/pubmed/36168221
http://dx.doi.org/10.1111/ina.13115
work_keys_str_mv AT ruetalonatalia inactivationofaerosolizedsarscov2by254nmuvcirradiation
AT bergersimon inactivationofaerosolizedsarscov2by254nmuvcirradiation
AT niessnerjennifer inactivationofaerosolizedsarscov2by254nmuvcirradiation
AT schindlermichael inactivationofaerosolizedsarscov2by254nmuvcirradiation